Suppr超能文献

血管紧张素相关蛋白104(AngRem104)是血管紧张素II诱导的人系膜细胞中一种新的上调基因,可能参与纤连蛋白表达的调控。

AngRem104, an angiotensin II-induced novel upregulated gene in human mesangial cells, is potentially involved in the regulation of fibronectin expression.

作者信息

Liang Xiubin, Zhang Hong, Zhou Anyu, Wang Haiyan

机构信息

Renal Division of Peking University First Hospital, Institute of Nephrology, Peking University, Beijing, China.

出版信息

J Am Soc Nephrol. 2003 Jun;14(6):1443-51. doi: 10.1097/01.asn.0000067860.64692.c0.

Abstract

Accumulation of extracellular matrix (ECM) in the glomerular mesangium is a common feature of many progressive renal diseases. Angiotensin II (AngII) plays important roles in the proliferation of glomerular mesangial cells (MC) as well as the synthesis of ECM such as fibronectin (FN) and collagens. However, the precise molecular signals responsible for these effects are unknown. To explore possible molecule mechanism of ECM accumulation related to AngII, suppression subtractive hybridization (SSH) was performed to screen and identify upregulated genes induced by AngII in cultured human MC. A novel gene, AngRem104 (GenBank accession number, AF367870), was isolated. The full-length cDNA of AngRem104 is 1690 bp, and it contains a 1041-bp open reading frame (ORF) encoding 347 amino acid residues with a predicted molecular mass of 37.2 kD. AngRem104 widely expressed in human heart, placenta, liver, muscle, kidney, and pancreas. Moreover, AngRem104 was found in human glomeruli and tubule by in situ hybridization. In human MC, the upregulation of AngRem104 induced by AngII was time-dependent, and it was dose-dependently blocked by AngII type 1 receptor antagonist (AT1RA), Losartan. The subcellular localization detected by AngRem104-pEGFP fusion protein revealed that AngRem104 was a nuclear protein. Interestingly, when AngRem104 was overexpressed by transfection of its sense construct, cDNA Microarray showed that two of the ECM-related genes, i.e., human mRNA for FN and integrin-beta-1 (FN receptor), dramatically upregulated their expressions. Furthermore, AngRem104 could regulate the expression of FN induced by AngII, which were detected by RT-PCR and quantitative real-time PCR, when AngRem104 was overexpressed. It is concluded that AngRem104 is a novel human gene potentially involved in the regulation of FN induced by AngII in human MC. These findings may provide new insights into mechanisms of glomerular sclerosis associated with AngII.

摘要

细胞外基质(ECM)在肾小球系膜中的积聚是许多进行性肾脏疾病的共同特征。血管紧张素II(AngII)在肾小球系膜细胞(MC)的增殖以及诸如纤连蛋白(FN)和胶原蛋白等ECM的合成中发挥重要作用。然而,导致这些效应的确切分子信号尚不清楚。为了探索与AngII相关的ECM积聚的可能分子机制,进行了抑制性消减杂交(SSH)以筛选和鉴定在培养的人MC中由AngII诱导的上调基因。分离出一个新基因,AngRem104(GenBank登录号,AF367870)。AngRem104的全长cDNA为1690 bp,它包含一个1041 bp的开放阅读框(ORF),编码347个氨基酸残基,预测分子量为37.2 kD。AngRem104在人心脏、胎盘、肝脏、肌肉、肾脏和胰腺中广泛表达。此外,通过原位杂交在人肾小球和肾小管中发现了AngRem104。在人MC中,AngII诱导的AngRem104上调是时间依赖性的,并且被1型血管紧张素II受体拮抗剂(AT1RA)氯沙坦剂量依赖性地阻断。通过AngRem104-pEGFP融合蛋白检测的亚细胞定位显示AngRem104是一种核蛋白。有趣的是,当通过转染其正义构建体使AngReml04过表达时,cDNA微阵列显示两个与ECM相关的基因,即人FN mRNA和整合素β-1(FN受体),其表达显著上调。此外,当AngRem104过表达时,通过RT-PCR和定量实时PCR检测到AngRem104可以调节由AngII诱导的FN的表达。结论是,AngRem104是一个新的人类基因,可能参与调节人MC中由AngII诱导的FN。这些发现可能为与AngII相关的肾小球硬化机制提供新的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验